To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Arms Length Body Publication (Published)
NICE

Jul. 16 2026

Source Page: Lutetium-177 vipovotide tetraxetan for treating PSMA-positive hormone-relapsed metastatic prostate cancer after an anti-androgen but not a taxane (terminated evaluation)
Publication Type: Summary PDF
Document: Download guidance (PDF) (webpage)
Arms Length Body Publication (Published)
NICE

Jul. 16 2026

Source Page: Netarsudil for treating open-angle glaucoma or ocular hypertension (terminated evaluation)
Publication Type: Summary PDF
Document: Download guidance (PDF) (webpage)
Arms Length Body Publication (Published)
NICE

Jul. 16 2026

Source Page: Lutetium-177 vipovotide tetraxetan for treating PSMA-positive hormone-relapsed metastatic prostate cancer after an anti-androgen but not a taxane (terminated evaluation)
Publication Type: Summary PDF
Document: Download guidance (PDF) (webpage)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Gemcitabine and paclitaxel albumin combination chemotherapy for the treatment of locally advanced non-metastatic pancreatic cancer (adults)
Document: Clinical commissioning policy: Gemcitabine and paclitaxel albumin combination chemotherapy for the treatment of locally advanced non-metastatic pancreatic cancer (adults) (PDF)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Lanreotide as a monotherapy for the treatment of symptomatic non-localised autosomal dominant polycystic liver disease (adults)
Document: Clinical commissioning policy: Lanreotide as a monotherapy for the treatment of symptomatic non-localised autosomal dominant polycystic liver disease (adults) (PDF)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Pembrolizumab in combination with dabrafenib and trametinib for patients with BRAF mutated anaplastic thyroid cancer (adults)
Document: Clinical commissioning policy: Pembrolizumab in combination with dabrafenib and trametinib for patients with BRAF mutated anaplastic thyroid cancer (adults) (PDF)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Combination brentuximab vedotin and bendamustine for patients aged 8 years and above with relapsed or refractory classical Hodgkin lymphoma
Document: Clinical commissioning policy: Combination brentuximab vedotin and bendamustine (BVB) for patients aged 8 years and above with relapsed or refractory classical Hodgkin lymphoma (PDF)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Lenacapavir for multi-drug resistant human immunodeficiency virus 1 infection (adults)
Document: Clinical commissioning policy: Lenacapavir for multi-drug resistant human immunodeficiency virus 1 infection (adults) (PDF)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Stereotactic radiosurgery for essential tremor refractory to medication (adults)
Document: Clinical commissioning policy: Stereotactic radiosurgery (SRS) for essential tremor refractory to medication (adults) (PDF)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Stereotactic ablative body radiotherapy for patients with localised, non-metastatic, renal cancer who are medically unfit for surgery (adults)
Document: Clinical commissioning policy: Stereotactic ablative body radiotherapy for patients with localised, non-metastatic, renal cancer who are medically unfit for surgery (adults) (PDF)